Hydroxyprogesterone caproate

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Link	Tested on	Impact factor	Notes	Publication date
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells: Nafamostat is the most potent antiviral drug candidate Preprint	Calu-3 human airway epithelial cells		lower IC50 value in Calu-3 cells than VERO E6 cells	May/12/2020

Link	Publication date
17alpha-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-kappaB Activation	Feb/07/2022